Kanvas Biosciences Raises $48M to Advance Spatial Biology Platform and Immuno-Oncology Trials
What You Should Know Kanvas Biosciences has raised $48M in Series A funding co-led by DCVC and Lions Capital LLC, bringing total funding to $78M. The capital will fund clinical…